Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

  1. Home
  2. PAAB Q&A
  3. Claims & Support/References for Claims
  4. Presenting recommendations for all drugs in class in a branded sense
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

Presenting recommendations for all drugs in class in a branded sense

Scheduled Pinned Locked Moved Claims & Support/References for Claims
1 Posts 1 Posters 26 Views
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • K Offline
    K Offline
    kshulist
    wrote last edited by
    #1

    Hi there,
    I was wondering if it was possible to present the consensus guidelines' recommendations for all products in a certain class in a branded sense?

    For example, DrugA, DrugB and DrugC are all the same class with the same indication in diseaseX. They are the only drugs in that class. Could we have a branded APS for DrugA where we neutrally present the recommendations for DrugsA-C in diseaseX (not necessarily verbatim, but accurately and within context without imparting new/different meaning than the guidelines)? If it helps, it would be a piece focused on the recommendations with no other data/claims about DrugA (but still containing the indication).

    I've seen this done in an unbranded piece, but was wondering if it could be done in a branded piece as well.

    Thank you!

    1 Reply Last reply
    0
    Reply
    • Reply as topic
    Log in to reply
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes


    • Login

    • Don't have an account? Register

    • Login or register to search.
    • First post
      Last post
    0
    • Categories
    • Recent
    • Tags
    • Popular
    • Users
    • Groups